Sponsor:
Palvella Therapeutics, Inc.
Code:
NCT06239480
Conditions
Microcystic Lymphatic Malformation
Eligibility Criteria
Sex: All
Age: 6+
Healthy Volunteers: Not accepted
Interventions
QTORIN 3.9% Rapamycin Anhydrous Gel
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations